Runciman William B, Roughead Elizabeth E, Semple Susan J, Adams Robert J
Department of Anaesthesia and Intensive Care, Level 4, Eleanor Harrald Building, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000, Australia.
Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59. doi: 10.1093/intqhc/mzg085.
To review information about adverse drug events (ADEs) and medication errors in Australia.
Systematic literature reviews and reports from data collections of the Australian Bureau of Statistics, Institute of Health and Welfare, Council for Health Care Standards and Patient Safety Foundation.
(medical record reviews): We have shown that 2-4% of all hospital admissions, and up to 30% for patients > 75 years of age, are medication-related; up to three-quarters are potentially preventable. RESULTS (routine data collections): Routine death certificate and hospital discharge data coded using the International Classification of Diseases capture less than half as many ADEs as medical record reviews. Of coded adverse events that contributed to death, 27% involved an ADE, as did 20% of adverse events identified at discharge and 43% at general practice encounters. There is a strong correlation between increases in medication use and rates of adverse drug reactions (ADRs) associated with hospitalization. RESULTS (drugs implicated): These were similar in all the above studies: anticoagulants, anti-inflammatory drugs, opioids, anti-neoplastics, antihypertensives, antibiotics, cardiac glycosides, diuretics, hypoglycaemic agents, steroids, hypnotics, anticonvulsants, and antipsychotics. RESULTS (clinical indicators): An ADE is reported in 1% of hospital admissions, while some hospitals do not report ADRs to the national collection. Only three-quarters of patients with acute myocardial infarction receive thrombolytics within 1 hour of presentation. Five per cent of patients on warfarin record an international normalized ratio > 5, and 1%, 0.05%, and 0.2% -suffer abnormal bleeding, cerebral haemorrhage, or death, respectively. RESULTS (the Australian Incident Monitoring System): Twenty-six per cent of 27 000 hospital-related incidents were medication-related, as were 36% of 2000 anaesthesia-related incidents, and 50% of 2500 general practice incidents. RESULTS (errors): Errors occur in 15-20% of drug administrations when ward stock systems are used and 5-8% when individual patient systems are used. Previous allergic reactions to drugs may not be recorded more than 75% of the time.
ADEs are common in the Australian health system. Anticoagulant, anti-inflammatory, and cardiovascular drugs feature prominently as preventable, high impact problems, and collectively make up over one-half of all ADEs. Methods for monitoring and preventing ADEs should be progressively improved.
回顾澳大利亚药物不良事件(ADEs)和用药错误的相关信息。
澳大利亚统计局、卫生与福利研究所、医疗保健标准委员会和患者安全基金会的数据收集所做的系统文献综述及报告。
(病历审查):我们已表明,所有住院病例中有2%-4%与用药相关,75岁以上患者这一比例高达30%;其中多达四分之三的情况有可能预防。结果(常规数据收集):使用国际疾病分类编码的常规死亡证明和医院出院数据所捕获的ADEs不及病历审查的一半。在导致死亡的编码不良事件中,27%涉及药物不良事件,出院时发现的不良事件中这一比例为20%,全科医疗会诊时为43%。用药量增加与住院相关的药物不良反应(ADRs)发生率之间存在很强的相关性。结果(涉及的药物):在上述所有研究中情况类似:抗凝剂、抗炎药、阿片类药物、抗肿瘤药、抗高血压药、抗生素、强心苷、利尿剂、降血糖药、类固醇、催眠药、抗惊厥药和抗精神病药。结果(临床指标):1%的住院病例报告有药物不良事件,而一些医院未向国家数据库报告药物不良反应。急性心肌梗死患者中只有四分之三在就诊后1小时内接受溶栓治疗。服用华法林的患者中有5%的国际标准化比值>5,1%、0.05%和0.2%的患者分别出现异常出血、脑出血或死亡。结果(澳大利亚事件监测系统):27000起与医院相关的事件中有26%与用药相关,2000起与麻醉相关的事件中有36%,2500起全科医疗事件中有50%。结果(错误):使用病房库存系统时,15%-20%的给药操作会出现错误,使用患者个人系统时这一比例为5%-8%。既往药物过敏反应记录缺失的情况超过75%。
药物不良事件在澳大利亚医疗系统中很常见。抗凝剂、抗炎药和心血管药物是突出的可预防且影响大的问题,共占所有药物不良事件的一半以上。应逐步改进药物不良事件的监测和预防方法。